Lidoderm Sales Data
| Rank 38 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Lidoderm U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 38 ( 3) |
$345,620 | -0.86% | 1,650 | -5.23% |
| Q4 2012 | 35 ( 5) |
$348,610 | 6.67% | 1,741 | 4.94% |
| Q3 2012 | 40 (5) |
$326,812 | 6.92% | 1,659 | 4.21% |
| Q2 2012 | 45 (4) |
$305,673 | 1.43% | 1,592 | 1.53% |
| Q1 2012 | 49 | $301,354 | -2.46% | 1,568 | -5.88% |
| Q4 2011 | 49 (3) |
$308,945 | 7.01% | 1,666 | 5.91% |
| Q3 2011 | 46 | $288,696 | -2.41% | 1,573 | -1.63% |
| Q2 2011 | 46 (6) |
$295,814 | 1.37% | 1,599 | -0.19% |
| Q1 2011 | 52 | $291,819 |  |
1,602 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
